BioPlus Acquisition Corp.
BioPlus Acquisition Corp. (BIOS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bios · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for BioPlus Acquisition Corp. (BIOS) measures how much investors pay for each dollar of the company's trailing earnings. BIOS's current PE ratio of 1249.89x is calculated by dividing its stock price of $10.79 by its TTM earnings per share of $0.01. +359.2% elevated vs 5Y avg 272.2x
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2001 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 7 fiscal years · Front-end computedMinQ1 · 25%24.3x
MedianQ3 · 75%1183.3x
Max
At 1249.89x, BIOS's current P/E is higher than in 100% of its annual fiscal year readings over the past 7 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Shell Companies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
BioPlus Acquisition Corp.You BIOS | $209M | 1249.89x | +3750.9% | $0.01 |
 Belong Acquisition Corp. BLNGW | $0M | 51.39x | +58.3% | $0.19 |
 Cascadia Acquisition Corp. CCAIW | $50M | 21.83x | -32.8% | $0.46 |
 ClimateRock CLRC | $56M | N/A | — | -$0.19 |
 Concord Acquisition Corp III CNDB | $83M | N/A | — | -$0.82 |
 DP Cap Acquisition Corp I DPCS | $91M | 47.46x | +46.2% | $0.23 |
 Iconic Sports Acquisition Corp. ICNC | $238M | 9.16x | -71.8% | $1.13 |
Industry Average 4 peers with valid PE | — | 32.46x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | 1183.31x | $0.01 | — | |
2021-12-31 FY2021 | — | $-0.02 | — | |
2018-12-31 FY2018 | — | $-0.40 | — | |
2017-12-31 FY2017 | — | $-1.06 | — | |
2016-12-31 FY2016 | — | $-0.37 | — | |
2015-12-31 FY2015 | — | $-2.37 | — | |
2014-12-31 FY2014 | — | $-2.09 | — | |
2013-12-31 FY2013 | — | $-0.83 | — | |
2012-12-31 FY2012 | — | $-0.15 | — | |
2011-12-31 FY2011 | — | $-0.60 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for BioPlus Acquisition Corp. (BIOS) measures how much investors pay for each dollar of the company's trailing earnings. BIOS's current PE ratio of 1249.89x is calculated by dividing its stock price of $10.79 by its TTM earnings per share of $0.01.
Frequently asked questions
BIOS pe ratio · 6 questionsBIOS's current PE ratio is 1249.89x as of 2026-06-09, based on a stock price of $10.79 and TTM EPS of $0.01. Data sourced from Financial Modeling Prep via BIOS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BioPlus Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09